Search research articles
Contact Us
Filters
Showing results (1-10 of 90) with videos related to
Page
of 9
Sort By:
Der Radiologe
|
September 28, 2000
[Interventions in hemodialysis shunts]
H Lorch
Cancer Management and Research
|
December 29, 2010
Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer
Jochen H Lorch
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
July 5, 2007
[Disclosure of diagnosis in ambulatory radiology practice: expectations of patients and referring physicians]
H Lorch, P Scherer
Cancer Cytopathology
|
November 8, 2021
Precision medicine in aggressive thyroid cancer: Moving beyond multitargeted tyrosine kinase inhibitors
Umair Mahmood, Jochen H Lorch
The Oncologist
|
June 5, 2015
Exceptional Responders Inspire Change: Lessons for Drug Development From the Bedside to the Bench and Back
Nicole G Chau, Jochen H Lorch
Frontiers in Oncology
|
March 3, 2025
Are all programmed cell death protein 1 inhibitors the same?
Jochen H Lorch, Stacey Stein, Martin J Edelman
Surgical Pathology Clinics
|
November 2, 2019
Treatment of Aggressive Thyroid Cancer
Julian Huang, Ethan James Harris, Jochen H Lorch
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
February 11, 2000
[The in-vitro evaluation of different embolectomy catheters for the treatment of acute pulmonary embolism]
M Zwaan, N Kripke, H Lorch, et al.
The Oncologist
|
February 28, 2013
Induction chemotherapy for locoregionally advanced head and neck cancer: past, present, future?
Glenn J Hanna, Robert I Haddad, Jochen H Lorch
Cardiovascular and Interventional Radiology
|
July 10, 2001
Central venous access ports placed by interventional radiologists: experience with 125 consecutive patients
H Lorch, M Zwaan, C Kagel, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 90) with videos related to
Sort By:
Page
of 9
Der Radiologe
|
September 28, 2000
[Interventions in hemodialysis shunts]
H Lorch
Cancer Management and Research
|
December 29, 2010
Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer
Jochen H Lorch
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
July 5, 2007
[Disclosure of diagnosis in ambulatory radiology practice: expectations of patients and referring physicians]
H Lorch, P Scherer
Cancer Cytopathology
|
November 8, 2021
Precision medicine in aggressive thyroid cancer: Moving beyond multitargeted tyrosine kinase inhibitors
Umair Mahmood, Jochen H Lorch
The Oncologist
|
June 5, 2015
Exceptional Responders Inspire Change: Lessons for Drug Development From the Bedside to the Bench and Back
Nicole G Chau, Jochen H Lorch
Frontiers in Oncology
|
March 3, 2025
Are all programmed cell death protein 1 inhibitors the same?
Jochen H Lorch, Stacey Stein, Martin J Edelman
Surgical Pathology Clinics
|
November 2, 2019
Treatment of Aggressive Thyroid Cancer
Julian Huang, Ethan James Harris, Jochen H Lorch
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
February 11, 2000
[The in-vitro evaluation of different embolectomy catheters for the treatment of acute pulmonary embolism]
M Zwaan, N Kripke, H Lorch, et al.
The Oncologist
|
February 28, 2013
Induction chemotherapy for locoregionally advanced head and neck cancer: past, present, future?
Glenn J Hanna, Robert I Haddad, Jochen H Lorch
Cardiovascular and Interventional Radiology
|
July 10, 2001
Central venous access ports placed by interventional radiologists: experience with 125 consecutive patients
H Lorch, M Zwaan, C Kagel, et al.
Page
of 9